GlassScriptPrepare for your visit
Carrie Hansen
Family · Claremont, NH · NPI 1710024963
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$1,446.70
in general payments reported to CMS, 2019-2025 · $628 in 2025
The $628 reported for 2025 was more than what 79% of Family providers received nationally (typical 2025 total: $167).
Who reported paying
General payments only, top 6 by amount.
- Genzyme Corporation $237.37
- Regeneron Healthcare Solutions, INC. $214.22
- Amgen INC. $179.60
- Galderma Laboratories, L.P. $151.29
- Abbvie INC. $144.21
- Janssen Biotech, INC. $133.62
Drugs and devices associated with these payments
Dupixent Rinvoq Otezla Tremfya Aklief Nemluvio Opzelura Sotyktu Spevigo Simponi Aria Stelara Simponi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Carrie Hansen listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/10947450/carrie-hansen